{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:04:20Z","timestamp":1788397460875,"version":"build-2803163510"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"33","license":[{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"University Medical Centre of the Johannes Gutenberg-University Mainz"},{"name":"German Ministry for Research"},{"DOI":"10.13039\/501100014584","name":"University Medical Center Mainz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014584","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>In a randomized, parallel, blinded study, we investigate the impact of clopidogrel, prasugrel, or ticagrelor on peripheral endothelial function in patients undergoing stenting for an acute coronary syndrome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>The primary endpoint of the study was the change in endothelium-dependent flow-mediated dilation (FMD) following stenting. A total of 90 patients (age 62\u2009\u00b1\u20099\u2009years, 81 males, 22 diabetics, 49 non-ST elevation myocardial infarctions) were enrolled. There were no significant differences among groups in any clinical parameter. Acutely before stenting, all three drugs improved FMD without differences between groups (P\u2009=\u20090.73). Stenting blunted FMD in the clopidogrel and ticagrelor group (both P\u2009&amp;lt;\u20090.01), but not in the prasugrel group. During follow-up, prasugrel was superior to clopidogrel [mean difference 2.13, 95% confidence interval (CI) 0.68\u20133.58; P\u2009=\u20090.0047] and ticagrelor (mean difference 1.57, 95% CI 0.31\u20132.83; P\u2009=\u20090.0155), but this difference was limited to patients who received the study therapy 2\u2009h before stenting. Ticagrelor was not significantly superior to clopidogrel (mean difference 0.55, 95% CI \u22120.73 to 1.82; P\u2009=\u20090.39). No significant differences were seen among groups for low-flow-mediated dilation. Plasma interleukin (IL)-6 (P\u2009=\u20090.02 and P\u2009=\u20090.01, respectively) and platelet aggregation reactivity in response to adenosine diphosphate (P\u2009=\u20090.002 and P\u2009=\u20090.035) were lower in the prasugrel compared to clopidogrel and ticagrelor group.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>As compared to ticagrelor and clopidogrel, therapy with prasugrel in patients undergoing stenting for an acute coronary syndrome is associated with improved endothelial function, stronger platelet inhibition, and reduced IL-6 levels, all of which may have prognostic implications. This effect was lost in patients who received the study medication immediately after stenting.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>EUDRACT-No<\/jats:title>\n                  <jats:p>2011-005305-73<\/jats:p>\n                  <jats:p\/>\n               <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehz917","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T20:09:53Z","timestamp":1575576593000},"page":"3144-3152","source":"Crossref","is-referenced-by-count":70,"title":["Effects of clopidogrel vs. prasugrel vs. ticagrelor on endothelial function, inflammatory parameters, and platelet function in patients with acute coronary syndrome undergoing coronary artery stenting: a randomized, blinded, parallel study"],"prefix":"10.1093","volume":"41","author":[{"given":"Boris","family":"Schnorbus","sequence":"first","affiliation":[{"name":"Zentrum f\u00fcr Kardiologie, Kardiologie I, Universit\u00e4tsmedizin Mainz, Johannes Gutenberg-University Mainz , Langenbeckstra\u00dfe 1, 55131 Mainz, Germany"},{"name":"Center for Thrombosis and Hemostasis, Universit\u00e4tsmedizin Mainz, Johannes Gutenberg-University Mainz , Langenbeckstra\u00dfe 1, 55131 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2769-0094","authenticated-orcid":false,"given":"Andreas","family":"Daiber","sequence":"additional","affiliation":[{"name":"Zentrum f\u00fcr Kardiologie, Kardiologie I, Universit\u00e4tsmedizin Mainz, Johannes Gutenberg-University Mainz , Langenbeckstra\u00dfe 1, 55131 Mainz, Germany"},{"name":"Deutsches Zentrum f\u00fcr Herz-Kreislauferkrankungen (DZHK), Standort Rhein-Main, Partnereinrichtung Mainz , Langenbeckstra\u00dfe 1, 55131 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5313-4035","authenticated-orcid":false,"given":"Kerstin","family":"Jurk","sequence":"additional","affiliation":[{"name":"Center for Thrombosis and Hemostasis, Universit\u00e4tsmedizin Mainz, Johannes Gutenberg-University Mainz , Langenbeckstra\u00dfe 1, 55131 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Warnke","sequence":"additional","affiliation":[{"name":"Interdisciplinary Center for Clinical Trials (IZKS), Universit\u00e4tsmedizin Mainz, Johannes Gutenberg-University Mainz , Langenbeckstra\u00dfe 1, 55131 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochem","family":"Koenig","sequence":"additional","affiliation":[{"name":"Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Johannes Gutenberg-University Mainz , Langenbeckstra\u00dfe 1, 55131 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl J","family":"Lackner","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, Universit\u00e4tsmedizin Mainz, Johannes Gutenberg-University Mainz , Langenbeckstra\u00dfe 1, 55131 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5503-4150","authenticated-orcid":false,"given":"Thomas","family":"M\u00fcnzel","sequence":"additional","affiliation":[{"name":"Zentrum f\u00fcr Kardiologie, Kardiologie I, Universit\u00e4tsmedizin Mainz, Johannes Gutenberg-University Mainz , Langenbeckstra\u00dfe 1, 55131 Mainz, Germany"},{"name":"Deutsches Zentrum f\u00fcr Herz-Kreislauferkrankungen (DZHK), Standort Rhein-Main, Partnereinrichtung Mainz , Langenbeckstra\u00dfe 1, 55131 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2917-6707","authenticated-orcid":false,"given":"Tommaso","family":"Gori","sequence":"additional","affiliation":[{"name":"Zentrum f\u00fcr Kardiologie, Kardiologie I, Universit\u00e4tsmedizin Mainz, Johannes Gutenberg-University Mainz , Langenbeckstra\u00dfe 1, 55131 Mainz, Germany"},{"name":"Deutsches Zentrum f\u00fcr Herz-Kreislauferkrankungen (DZHK), Standort Rhein-Main, Partnereinrichtung Mainz , Langenbeckstra\u00dfe 1, 55131 Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,1,3]]},"reference":[{"key":"2022102615081704100_ehz917-B1","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0735-1097(02)02014-4","article-title":"Effect of additional temporary glycoprotein IIb\/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial)","volume":"40","author":"Bonz","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2022102615081704100_ehz917-B2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0002-8703(03)00407-1","article-title":"Diagnostic coronary angiography induces a systemic inflammatory response in patients with stable angina","volume":"146","author":"Goldberg","year":"2003","journal-title":"Am Heart J"},{"key":"2022102615081704100_ehz917-B3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1067\/mhj.2003.16","article-title":"Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease","volume":"145","author":"Almagor","year":"2003","journal-title":"Am Heart J"},{"key":"2022102615081704100_ehz917-B4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00019501-200412000-00003","article-title":"Soluble CD40 ligand is an early initiator of inflammation after coronary intervention","volume":"15","author":"Aggarwal","year":"2004","journal-title":"Coron Artery Dis"},{"key":"2022102615081704100_ehz917-B5","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0002-9149(03)00971-8","article-title":"Comparison of inflammatory markers in patients with diabetes mellitus versus those without before and after coronary arterial stenting","volume":"92","author":"Aggarwal","year":"2003","journal-title":"Am J Cardiol"},{"key":"2022102615081704100_ehz917-B6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1023\/A:1026188200939","article-title":"Increase in interleukin-6 in the first hour after coronary stenting: an early marker of the inflammatory response","volume":"15","author":"Aggarwal","year":"2003","journal-title":"J Thromb Thrombolysis"},{"key":"2022102615081704100_ehz917-B7","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0002-9149(03)00327-8","article-title":"Comparison of effects of abciximab versus eptifibatide on C-reactive protein, interleukin-6, and interleukin-1 receptor antagonist after coronary arterial stenting","volume":"91","author":"Aggarwal","year":"2003","journal-title":"Am J Cardiol"},{"key":"2022102615081704100_ehz917-B8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3233\/CH-2012-1578","article-title":"Clinical importance of antiplatelet drugs in cardiovascular diseases","volume":"53","author":"Papp","year":"2013","journal-title":"Clin Hemorheol Microcirc"},{"key":"2022102615081704100_ehz917-B9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3233\/CH-2012-1577","article-title":"Platelets in vascular disease","volume":"53","author":"Reinhart","year":"2013","journal-title":"Clin Hemorheol Microcirc"},{"key":"2022102615081704100_ehz917-B10","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1161\/CIRCULATIONAHA.109.876763","article-title":"C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation","volume":"120","author":"Park","year":"2009","journal-title":"Circulation"},{"key":"2022102615081704100_ehz917-B11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.amjcard.2004.08.057","article-title":"Effect of tirofiban on percutaneous coronary intervention-induced endothelial dysfunction in patients with stable coronary artery disease","volume":"95","author":"Warnholtz","year":"2005","journal-title":"Am J Cardiol"},{"key":"2022102615081704100_ehz917-B12","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/eurheartj\/ehq401","article-title":"Brachial artery low-flow-mediated constriction is increased early after coronary intervention and reduces during recovery after acute coronary syndrome: characterization of a recently described index of vascular function","volume":"32","author":"Spiro","year":"2011","journal-title":"Eur Heart J"},{"key":"2022102615081704100_ehz917-B13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123838","article-title":"Endothelial function: a short guide for the interventional cardiologist","volume":"19","author":"Gori","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2022102615081704100_ehz917-B14","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1161\/01.CIR.0000081774.31064.62","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease","volume":"108","author":"Heitzer","year":"2003","journal-title":"Circulation"},{"key":"2022102615081704100_ehz917-B15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00392-010-0199-6","article-title":"Lack of evidence for pleiotropic effects of clopidogrel on endothelial function and inflammation in patients with stable coronary artery disease: results of the double-blind, randomized CASSANDRA study","volume":"100","author":"Ostad","year":"2011","journal-title":"Clin Res Cardiol"},{"key":"2022102615081704100_ehz917-B16","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.atherosclerosis.2006.12.009","article-title":"A single loading dose of clopidogrel causes dose-dependent improvement of endothelial dysfunction in patients with stable coronary artery disease: results of a double-blind, randomized study","volume":"196","author":"Warnholtz","year":"2008","journal-title":"Atherosclerosis"},{"key":"2022102615081704100_ehz917-B17","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1080\/09537104.2018.1513479","article-title":"Effects of different doses of ticagrelor on platelet aggregation and endothelial function in diabetic patients with stable coronary artery disease","volume":"30","author":"He","year":"2019","journal-title":"Platelets"},{"key":"2022102615081704100_ehz917-B18","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jcin.2018.04.022","article-title":"Effects of ticagrelor, prasugrel, or clopidogrel on endothelial function and other vascular biomarkers: a randomized crossover study","volume":"11","author":"Ariotti","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102615081704100_ehz917-B19","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.jcin.2017.05.064","article-title":"Comparison of ticagrelor versus prasugrel for inflammation, vascular function, and circulating endothelial progenitor cells in diabetic patients with non-ST-segment elevation acute coronary syndrome requiring coronary stenting: a prospective, randomized, crossover trial","volume":"10","author":"Jeong","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102615081704100_ehz917-B20","doi-asserted-by":"crossref","first-page":"e005268.","DOI":"10.1136\/bmjopen-2014-005268","article-title":"Effects of clopidogrel, prasugrel and ticagrelor on endothelial function, inflammatory and oxidative stress parameters and platelet function in patients undergoing coronary artery stenting for an acute coronary syndrome. A randomised, prospective, controlled study","volume":"4","author":"Schnorbus","year":"2014","journal-title":"BMJ Open"},{"key":"2022102615081704100_ehz917-B21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/eurheartj\/ehr361","article-title":"Endothelial function assessment: flow-mediated dilation and constriction provide different and complementary information on the presence of coronary artery disease","volume":"33","author":"Gori","year":"2012","journal-title":"Eur Heart J"},{"key":"2022102615081704100_ehz917-B22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3233\/CH-2012-1603","article-title":"Endothelial function and hemorheological parameters modulate coronary blood flow in patients without significant coronary artery disease","volume":"52","author":"Gori","year":"2012","journal-title":"Clin Hemorheol Microcirc"},{"key":"2022102615081704100_ehz917-B23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/CH-2010-1288","article-title":"Endothelial functions: translating theory into clinical application","volume":"45","author":"Muxel","year":"2010","journal-title":"Clin Hemorheol Microcirc"},{"key":"2022102615081704100_ehz917-B24","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.jacc.2008.01.049","article-title":"Conduit artery constriction mediated by low flow a novel noninvasive method for the assessment of vascular function","volume":"51","author":"Gori","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2022102615081704100_ehz917-B25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/hrt.2009.167213","article-title":"Assessment of vascular function: flow-mediated constriction complements the information of flow-mediated dilatation","volume":"96","author":"Gori","year":"2010","journal-title":"Heart"},{"key":"2022102615081704100_ehz917-B26","doi-asserted-by":"crossref","first-page":"738545","DOI":"10.1155\/2008\/738545","article-title":"Model-based analysis of flow-mediated dilation and intima-media thickness","volume":"2008","author":"Bartoli","year":"2008","journal-title":"Int J Biomed Imaging"},{"key":"2022102615081704100_ehz917-B27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.5482\/HAMO-14-09-0047","article-title":"Analysis of platelet function and dysfunction","volume":"35","author":"Jurk","year":"2015","journal-title":"Hamostaseologie"},{"key":"2022102615081704100_ehz917-B28","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0002-9149(99)00839-5","article-title":"Short- and medium-term outcome differences in women and men after primary percutaneous transluminal mechanical revascularization for acute myocardial infarction","volume":"85","author":"Azar","year":"2000","journal-title":"Am J Cardiol"},{"key":"2022102615081704100_ehz917-B29","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jcin.2011.05.025","article-title":"Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis","volume":"4","author":"Inoue","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102615081704100_ehz917-B30","first-page":"9","article-title":"In-stent coronary restenosis, but not the type of stent, is associated with impaired endothelial-dependent vasodilatation","volume":"67","author":"Mizia-Stec","year":"2009","journal-title":"Kardiol Pol"},{"key":"2022102615081704100_ehz917-B31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijcard.2006.09.021","article-title":"Local vascular dysfunction after coronary paclitaxel-eluting stent implantation","volume":"120","author":"Togni","year":"2007","journal-title":"Int J Cardiol"},{"key":"2022102615081704100_ehz917-B32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/eurheartj\/ehi571","article-title":"Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation","volume":"27","author":"Hofma","year":"2006","journal-title":"Eur Heart J"},{"key":"2022102615081704100_ehz917-B33","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jacc.2007.06.031","article-title":"Sirolimus-eluting stent implantation aggravates endothelial vasomotor dysfunction in the infarct-related coronary artery in patients with acute myocardial infarction","volume":"50","author":"Obata","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2022102615081704100_ehz917-B34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacc.2006.08.043","article-title":"Coronary collateral function long after drug-eluting stent implantation","volume":"49","author":"Meier","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2022102615081704100_ehz917-B35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.atherosclerosis.2006.05.050","article-title":"Sequential patterns of chemokine- and chemokine receptor-synthesis following vessel wall injury in porcine coronary arteries","volume":"192","author":"Jabs","year":"2007","journal-title":"Atherosclerosis"},{"key":"2022102615081704100_ehz917-B36","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1172\/JCI27196","article-title":"Platelets in inflammation and atherogenesis","volume":"115","author":"Gawaz","year":"2005","journal-title":"J Clin Invest"},{"key":"2022102615081704100_ehz917-B37","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1089\/ars.2013.5527","article-title":"Statins as regulators of redox signaling in platelets","volume":"20","author":"Violi","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"2022102615081704100_ehz917-B38","first-page":"263","article-title":"The correlation between early complications of percutaneous coronary intervention and high sensitive C-reactive protein","volume":"9","author":"Roghani","year":"2013","journal-title":"ARYA Atheroscler"},{"key":"2022102615081704100_ehz917-B39","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMoa1908973","article-title":"Ticagrelor or prasugrel in patients with acute coronary syndromes","volume":"381","author":"Schupke","year":"2019","journal-title":"N Engl J Med"},{"key":"2022102615081704100_ehz917-B40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1160\/TH09-03-0177","article-title":"Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients","volume":"103","author":"Muhlestein","year":"2010","journal-title":"Thromb Haemost"},{"key":"2022102615081704100_ehz917-B41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00029330-200601010-00006","article-title":"Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome","volume":"119","author":"Chen","year":"2006","journal-title":"Chin Med J (Engl)"},{"key":"2022102615081704100_ehz917-B42","doi-asserted-by":"crossref","first-page":"521.e1","DOI":"10.1016\/j.ahj.2005.10.021","article-title":"Effects of clopidogrel on soluble CD40 ligand and on high-sensitivity C-reactive protein in patients with stable coronary artery disease","volume":"151","author":"Azar","year":"2006","journal-title":"Am Heart J"},{"key":"2022102615081704100_ehz917-B43","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.amjcard.2003.11.048","article-title":"Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention","volume":"93","author":"Quinn","year":"2004","journal-title":"Am J Cardiol"},{"key":"2022102615081704100_ehz917-B44","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2003.10.071","article-title":"Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome","volume":"43","author":"Xiao","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2022102615081704100_ehz917-B45","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.clinthera.2006.06.010","article-title":"Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels","volume":"28","author":"Vavuranakis","year":"2006","journal-title":"Clin Ther"},{"key":"2022102615081704100_ehz917-B46","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.jacc.2005.12.084","article-title":"Effect of clopidogrel with and without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting: results from the CLEAR PLATELETS 1b study","volume":"48","author":"Gurbel","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2022102615081704100_ehz917-B47","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1527-3466.2007.00027.x","article-title":"Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile","volume":"25","author":"Jakubowski","year":"2007","journal-title":"Cardiovasc Drug Rev"},{"key":"2022102615081704100_ehz917-B48","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1160\/TH08-05-0313","article-title":"Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease","volume":"100","author":"Braun","year":"2008","journal-title":"Thromb Haemost"},{"key":"2022102615081704100_ehz917-B49","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/pgmj.2006.047696","article-title":"Platelet inhibition with prasugrel (CS-747) compared with clopidogrel in patients undergoing coronary stenting: the subset from the JUMBO study","volume":"82","author":"Serebruany","year":"2006","journal-title":"Postgrad Med J"},{"key":"2022102615081704100_ehz917-B50","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9343(99)00066-2","article-title":"Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly","volume":"106","author":"Harris","year":"1999","journal-title":"Am J Med"},{"key":"2022102615081704100_ehz917-B51","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jacc.2010.09.050","article-title":"High versus standard clopidogrel maintenance dose after percutaneous coronary intervention and effects on platelet inhibition, endothelial function, and inflammation results of the ARMYDA-150 mg (antiplatelet therapy for reduction of myocardial damage during angioplasty) randomized study","volume":"57","author":"Patti","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2022102615081704100_ehz917-B52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2017.06.099","article-title":"Prasugrel as opposed to clopidogrel improves endothelial nitric oxide bioavailability and reduces platelet-leukocyte interaction in patients with unstable angina pectoris: a randomized controlled trial","volume":"248","author":"Rudolph","year":"2017","journal-title":"Int J Cardiol"},{"key":"2022102615081704100_ehz917-B53","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/ccd.21007","article-title":"Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis","volume":"69","author":"Caixeta","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"2022102615081704100_ehz917-B54","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1093\/eurheartj\/ehy633","article-title":"Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions","volume":"39","author":"Kalkman","year":"2018","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/41\/33\/3144\/46646107\/eurheartj_41_33_3144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/41\/33\/3144\/46646107\/eurheartj_41_33_3144.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T15:41:38Z","timestamp":1666798898000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/41\/33\/3144\/5695774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,3]]},"references-count":54,"journal-issue":{"issue":"33","published-online":{"date-parts":[[2020,1,3]]},"published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehz917","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9,1]]},"published":{"date-parts":[[2020,1,3]]}}}